Watson Pharmaceuticals announced that the company previously became the marketing license holder for Jianer's Digestive Oral Liquid in September 2025; it recently received the “Notice of Approval of the Drug Supplement Application” approved and issued by the State Drug Administration, which approved changes to the safety and other content in the drug manual. The notice number is 2026B06473.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.